Publications

  • HOME
  • Publications
  • Publications
  • 33. Synthetic Approach to Flavanones and Flavones via Ligand-Free Palladium(II)-Catalyzed Conjugate Addition of Aryl-boronic Acids to Chromones

    Kim, D.; Ham, K.; Hong, S.

    Org. Biomol. Chem. 2012, 10, 7305. (Highlighted as a Front Cover)

  • 32. Discovery of MEK/PI3K Dual Inhibitor via Structure-Based Virtual Screening 

    Park, H.; Lee, S.; Hong, S.

    Bioorg. Med. Chem. Lett. 2012, 22, 4946.

  • 31. Selectivity Enhancement Arising from Interactions at the PI3K Unique Pocket 

    Jeong, Y.; Lee, J.; Lee, Y.; Ham, K.; Choi, S.; Hong, S.

    ChemMedChem. 20127, 1379-1383

  • 30. A Facile Route to Isoflavone Quinones via the Direct Cross-Coupling of Chromones and Quinones

    Moon, Y.; Hong, S. 

    Chem. Commun. 2012, 48, 7191-7193.

  • 29. Regioselective Cross-Dehydrogenative Coupling of Chromones and Nonactivated Arenes

    Min, M.; Choe, H.; Hong, S.

    Asian. J. Org. Chem. 2012, 1, 47-50. (Highlighted as a Front Inside Cover) 

  • 28. Design, Synthesis and Evaluation of 3,5-Disubstituted 7-Azaindoles as Trk Inhibitors with Anticancer and Anti-angiogenic Activities 

    Hong, S.; Kim, J.; Seo, J.; Jung, K.; Hong, S.-S.; Hong, S.

    J. Med. Chem. 201255, 5337-5349.

  • 27. The Effect of HS-111, a Novel Thiazolamine Derivative, on Apoptosis and Angiogenesis of Hepatocellular Carcinoma Cells 

    Choi, M.-J.; Lee, H.; Lee, J.-H.; Jung, K. H.; Kim, D.; Hong, S.*; Hong, S.-S.*

    Arch. Pharm. Res201235, 747-754.

  • 26. Structure-Based Virtual Screening Approach to the Discovery of p38 MAP Kinase Inhibitors 

    Choi, H.; Park, H.; Shin, J. C.; Ko, H. S.; Lee, J. K.; Lee, S.; Park, H.; Hong, S.

    Bioorg. Med. Chem. Lett. 2012, 22, 2195-2199.

  • 25. Direct C–H Cross-Coupling Approach to Heteroaryl Coumarins 

    Min, M.; Kim, B.; Hong, S.

    Org. Biomol. Chem. 2012, 10, 2692-2698. (Top ten most accessed article)

  • 24. HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway 

    Jung, K. H.; Choi, M.-J.; Hong, S.; Lee, H.; Hong, S.-W.; Zheng, H.-M.; Lee, H. S.; Hong, S.*; Hong, S.-S.*

    Cancer Lett. 2012, 316, 187-195.